missing translation for 'onlineSavingsMsg'
Läs mer

Integrin alpha E/CD103 Antibody (Ber-ACT8), PE/Atto594, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP1-97564PEATT594

Produktkod. 18001098

  • 5325.00 SEK / 0.10ml

Vänligen för att beställa denna produkten. Behöver du ett Webbkonto? Registrera ditt konto idag!

This item is not returnable. View return policy

Description

Description

Integrin alpha E/CD103 Monoclonal specifically detects Integrin alpha E/CD103 in Human, Primate samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Integrin alpha E/CD103
Monoclonal
PE/ATTO 594
PBS with 0.05% Sodium Azide
ITGAE
HTLV-1 induced human T cell line MAPS16
0.1 mL
Primary
The mouse monoclonal antibody Ber-ACT8 recognizes an extracellular epitope of CD103 (alpha E integrin), a type I transmembrane glycoprotein primarily found on intestinal intraepithelial lymphocytes. HLDA V; WS Code A067
Store at 4°C in the dark. Do not freeze.
Flow Cytometry
Ber-ACT8
Flow Cytometry
antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide, CD103, CD103 antigen, HML-1 antigen, HUMINAE, integrin alpha-E, Integrin alpha-IEL, integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alphapolypeptide), MGC141996, Mucosal lymphocyte 1 antigen
Mouse
Protein A purified
Innate Immunity
3682.0
Human, Primate
IgG1 κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.